InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M

9 February, 2021

NEWS

16 February, 2021

InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors

9 February, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M

7 January, 2021

Vacancy for a highly motivated PhD student to join the RnD Research team with a keen interest on “ The endo-lysosomal processes in metabolic disease development and therapeutic efficacy”

6 January, 2021

InteRNA in de Kerstbijlage van het Algemeen Dagblad d.d. 17 december 2020: Nieuwe vorm van immunotherapie helpt bij de bestrijding van kanker.

20 May, 2020

CATO SMS Signs Agreement with InteRNA to Facilitate Phase I Solid Tumor Trial

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-38